Journal ArticleDOI
Risk Factors for 30-Day Readmission in Adults with Sickle Cell Disease.
Max A. Brodsky,Mark Rodeghier,Maureen Sanger,Jeannie Byrd,Brandi L. McClain,Brittany Covert,Dionna O. Roberts,Karina Wilkerson,Michael R. DeBaun,Adetola A. Kassim +9 more
TLDR
Improved discharge planning and ensuring access to a primary care provider may decrease the 30-day readmission rate in adults with sickle cell disease.About:
This article is published in The American Journal of Medicine.The article was published on 2017-05-01. It has received 31 citations till now. The article focuses on the topics: Odds ratio & Medical record.read more
Citations
More filters
Journal ArticleDOI
Building access to care in adult sickle cell disease: Defining models of care, essential components, and economic aspects
Julie Kanter,Wally R. Smith,Payal C. Desai,Marsha Treadwell,Biree Andemariam,Jane A. Little,Diane J. Nugent,Susan Claster,Deepa Manwani,Judith Baker,John J. Strouse,Ifeyinwa Osunkwo,Rosalyn W. Stewart,Allison A. King,Lisa M Shook,Lisa M Shook,John D. Roberts,Sophie Lanzkron +17 more
TL;DR: As more clinicians are trained in providing adult-focused SCD care, center designation will enhance the ability to undertake quality improvement and compare outcomes between SCD centers, as part of a workshop designed to train health care professionals in the skills necessary to establish clinical centers focused on the management of adults living with SCD.
Journal ArticleDOI
Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study
Robert M. Cronin,Jane S. Hankins,Jeannie Byrd,Brandi Pernell,Brandi Pernell,Adetola A. Kassim,Patricia Adams-Graves,Alexis A. Thompson,Karen Kalinyak,Michael R. DeBaun,Marsha Treadwell +10 more
TL;DR: Findings confirm that age, mental health, financial insecurity, spirituality, and clinic attendance are all modifiable factors that are associated with admissions and readmissions; addressing them could reduce hospitalizations.
Journal ArticleDOI
Barriers to Care for Persons With Sickle Cell Disease: The Case Manager's Opportunity to Improve Patient Outcomes.
TL;DR: In this article, the authors discuss the barriers to care for patients with SCD and suggest specific interventions within the role of the case manager that can improve care delivered and ultimately contribute to improved patient outcomes.
Journal ArticleDOI
Cerebral oxygen metabolism in adults with sickle cell disease.
Lena Václavů,Lena Václavů,Jan Petr,Esben Thade Petersen,Esben Thade Petersen,Henri J.M.M. Mutsaerts,Charles B. L. Majoie,John C. Wood,Ed VanBavel,Aart J. Nederveen,Bart J. Biemond +10 more
TL;DR: It is hypothesized that adults with SCD have impairedCMRO2 at rest and that a vasodilatory challenge with acetazolamide would improve CMRO2, which could reflect variation between healthy and unhealthy vascular beds in terms of dilatory capacity and resistance whereby dysfunctional vessels become more oxygen‐deprived, hence increasing the risk of localized ischemia.
Journal ArticleDOI
Modifying factors of the health belief model associated with missed clinic appointments among individuals with sickle cell disease.
Robert M. Cronin,Jane S. Hankins,Jeannie Byrd,Brandi Pernell,Brandi Pernell,Adetola A. Kassim,Patricia Adams-Graves,Alexis A. Thompson,Karen Kalinyak,Michael R. DeBaun,Marsha Treadwell +10 more
TL;DR: Modifying components of the Health Belief Model, including age, financial security, health literacy, spirituality, and lacking cues to action like reminders, are important in missed appointments and addressing these factors could improve appointment-keeping for adults and children with SCD.
References
More filters
Journal ArticleDOI
Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell Anemia
Samuel Charache,Michael L. Terrin,Richard D. Moore,George J. Dover,Franca B. Barton,Susan V. Eckert,Robert P. McMahon,Duane Bonds +7 more
TL;DR: Hydroxyurea therapy can ameliorate the clinical course of sickle cell anemia in some adults with three or more painful crises per year and Maximal tolerated doses of hydroxyurea may not be necessary to achieve a therapeutic effect.
Journal ArticleDOI
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)
Madeleine Duvic,Rakhshandra Talpur,Xiao Ni,Chunlei Zhang,Parul Hazarika,Cecilia Kelly,Judy Chiao,John F. Reilly,Justin L. Ricker,Victoria M. Richon,Stanley R. Frankel +10 more
TL;DR: Vorinostat demonstrated activity in heavily pretreated patients with CTCL and the 400 mg daily regimen had the most favorable safety profile and is being further evaluated.
Journal ArticleDOI
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)
Winfred C. Wang,Russell E. Ware,Scott T. Miller,Rathi V. Iyer,James F. Casella,Caterina P. Minniti,Sohail Rana,Courtney D. Thornburg,Zora R. Rogers,Ram Kalpatthi,Julio C. Barredo,R. Clark Brown,Sharada A. Sarnaik,Thomas H. Howard,Lynn W. Wynn,Abdullah Kutlar,F. Daniel Armstrong,Beatrice Files,Jonathan C. Goldsmith,Myron A. Waclawiw,Xiangke Huang,Bruce W. Thompson +21 more
TL;DR: Hydroxycarbamide can now be considered for all very young children with sickle-cell anaemia, with some evidence for decreased acute chest syndrome, hospitalisation rates, and transfusion.
Journal ArticleDOI
Chronic Illness Management: What Is the Role of Primary Care?
TL;DR: The characteristics of practice systems associated with better chronic illness care and a conceptual model for improving such care are discussed and evidence that may shed light on this issue is considered.
Journal ArticleDOI
Acute Care Utilization and Rehospitalizations for Sickle Cell Disease
David C. Brousseau,Pamela L Owens,Pamela L Owens,Pamela L Owens,Andrew Mosso,Julie A. Panepinto,Claudia A Steiner +6 more
TL;DR: Among patients with sickle cell disease, acute care encounters and rehospitalizations were frequent, particularly for 18- to 30-year-olds, and population-based utilization rates were calculated.
Related Papers (5)
Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance.
Samir K. Ballas,Margaret Lusardi +1 more